APO Research
Talk to an analyst

APO RESEARCH · REPORT

MET TKIs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global MET TKIs Industry Growth and Trends Forecast to 2032

27 December 2025117 pages

Choose your research edition.

Industry ResearchMET TKIs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal MET TKIs Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal MET TKIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal MET TKIs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal MET TKIs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global MET TKIs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of MET TKIs include Wanbang Biopharmaceuticals, CSPC Pharmaceutical, Asymchem, Shanghai Hutchison Pharmaceuticals, WuXi STA, Haihe Biopharma, Avistone Pharmaceuticals Biotechnology, Zydus and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global MET TKIs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The MET TKIs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global MET TKIs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to MET TKIs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global MET TKIs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

MET TKIs Market by Company

Wanbang Biopharmaceuticals

CSPC Pharmaceutical

Asymchem

Shanghai Hutchison Pharmaceuticals

WuXi STA

Haihe Biopharma

Avistone Pharmaceuticals Biotechnology

Zydus

Teva

Pfizer

Novartis

Merck

Genvio Pharma

Exelixis

Everest Pharmaceuticals

Drug International

Cipla

Beacom

BDR Pharma

MET TKIs Segment by Type

Multi-target Inhibitors

Single-target Inhibitors

MET TKIs Segment by Application

Non-small Cell Lung Cancer

Medullary Thyroid Cancer

Other

MET TKIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MET TKIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of MET TKIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MET TKIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of MET TKIs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Multi-target Inhibitors Table 2. Major Company of Single-target Inhibitors Table 3. Global MET TKIs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global MET TKIs Sales by Type (2021-2026) & (K Units) Table 5. Global MET TKIs Sales Market Share in Volume by Type (2021-2026) Table 6. Global MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 7. Global MET TKIs Sales Market Share in Value by Type (2021-2026) Table 8. Global MET TKIs Price by Type (2021-2026) & (US$/Unit) Table 9. Global MET TKIs Sales by Type (2027-2032) & (K Units) Table 10. Global MET TKIs Sales Market Share in Volume by Type (2027-2032) Table 11. Global MET TKIs Sales by Type (2027-2032) & (US$ Million) Table 12. Global MET TKIs Sales Market Share in Value by Type (2027-2032) Table 13. Global MET TKIs Price by Type (2027-2032) & (US$/Unit) Table 14. North America MET TKIs Sales by Type (2021-2026) & (K Units) Table 15. North America MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe MET TKIs Sales by Type (2021-2026) & (K Units) Table 17. Europe MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific MET TKIs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America MET TKIs Sales by Type (2021-2026) & (K Units) Table 21. Latin America MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa MET TKIs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 24. MET TKIs Industry Trends Table 25. MET TKIs Industry Drivers Table 26. MET TKIs Industry Opportunities and Challenges Table 27. MET TKIs Industry Restraints Table 28. Global MET TKIs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global MET TKIs Revenue Market Share by Company (2021-2026) Table 30. Global MET TKIs Sales by Company (2021-2026) & (K Units) Table 31. Global MET TKIs Sales Share by Company (2021-2026) Table 32. Global MET TKIs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global MET TKIs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global MET TKIs Major Company Production Sites and Headquarters Table 35. Global MET TKIs Company, Product Type & Application Table 36. Global MET TKIs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global MET TKIs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global MET TKIs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global MET TKIs Sales by Region (2021-2026) & (K Units) Table 41. Global MET TKIs Sales Market Share in Volume by Region (2021-2026) Table 42. Global MET TKIs Sales by Region (2021-2026) & (US$ Million) Table 43. Global MET TKIs Sales Market Share in Value by Region (2021-2026) Table 44. Global MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global MET TKIs Sales by Region (2027-2032) & (K Units) Table 46. Global MET TKIs Sales Market Share in Volume by Region (2027-2032) Table 47. Global MET TKIs Sales by Region (2027-2032) & (US$ Million) Table 48. Global MET TKIs Sales Market Share in Value by Region (2027-2032) Table 49. Global MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global MET TKIs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global MET TKIs Sales by Application (2021-2026) & (K Units) Table 52. Global MET TKIs Sales Market Share in Volume by Application (2021-2026) Table 53. Global MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 54. Global MET TKIs Sales Market Share in Value by Application (2021-2026) Table 55. Global MET TKIs Price by Application (2021-2026) & (US$/Unit) Table 56. Global MET TKIs Sales by Application (2027-2032) & (K Units) Table 57. Global MET TKIs Sales Market Share in Volume by Application (2027-2032) Table 58. Global MET TKIs Sales by Application (2027-2032) & (US$ Million) Table 59. Global MET TKIs Sales Market Share in Value by Application (2027-2032) Table 60. Global MET TKIs Price by Application (2027-2032) & (US$/Unit) Table 61. North America MET TKIs Sales by Application (2021-2026) & (K Units) Table 62. North America MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe MET TKIs Sales by Application (2021-2026) & (K Units) Table 64. Europe MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific MET TKIs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America MET TKIs Sales by Application (2021-2026) & (K Units) Table 68. Latin America MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa MET TKIs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 71. Wanbang Biopharmaceuticals Company Information Table 72. Wanbang Biopharmaceuticals Business Overview Table 73. Wanbang Biopharmaceuticals MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Wanbang Biopharmaceuticals MET TKIs Product Portfolio Table 75. Wanbang Biopharmaceuticals Recent Development Table 76. CSPC Pharmaceutical Company Information Table 77. CSPC Pharmaceutical Business Overview Table 78. CSPC Pharmaceutical MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. CSPC Pharmaceutical MET TKIs Product Portfolio Table 80. CSPC Pharmaceutical Recent Development Table 81. Asymchem Company Information Table 82. Asymchem Business Overview Table 83. Asymchem MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Asymchem MET TKIs Product Portfolio Table 85. Asymchem Recent Development Table 86. Shanghai Hutchison Pharmaceuticals Company Information Table 87. Shanghai Hutchison Pharmaceuticals Business Overview Table 88. Shanghai Hutchison Pharmaceuticals MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolio Table 90. Shanghai Hutchison Pharmaceuticals Recent Development Table 91. WuXi STA Company Information Table 92. WuXi STA Business Overview Table 93. WuXi STA MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. WuXi STA MET TKIs Product Portfolio Table 95. WuXi STA Recent Development Table 96. Haihe Biopharma Company Information Table 97. Haihe Biopharma Business Overview Table 98. Haihe Biopharma MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Haihe Biopharma MET TKIs Product Portfolio Table 100. Haihe Biopharma Recent Development Table 101. Avistone Pharmaceuticals Biotechnology Company Information Table 102. Avistone Pharmaceuticals Biotechnology Business Overview Table 103. Avistone Pharmaceuticals Biotechnology MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolio Table 105. Avistone Pharmaceuticals Biotechnology Recent Development Table 106. Zydus Company Information Table 107. Zydus Business Overview Table 108. Zydus MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Zydus MET TKIs Product Portfolio Table 110. Zydus Recent Development Table 111. Teva Company Information Table 112. Teva Business Overview Table 113. Teva MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Teva MET TKIs Product Portfolio Table 115. Teva Recent Development Table 116. Pfizer Company Information Table 117. Pfizer Business Overview Table 118. Pfizer MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Pfizer MET TKIs Product Portfolio Table 120. Pfizer Recent Development Table 121. Novartis Company Information Table 122. Novartis Business Overview Table 123. Novartis MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Novartis MET TKIs Product Portfolio Table 125. Novartis Recent Development Table 126. Merck Company Information Table 127. Merck Business Overview Table 128. Merck MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Merck MET TKIs Product Portfolio Table 130. Merck Recent Development Table 131. Genvio Pharma Company Information Table 132. Genvio Pharma Business Overview Table 133. Genvio Pharma MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Genvio Pharma MET TKIs Product Portfolio Table 135. Genvio Pharma Recent Development Table 136. Exelixis Company Information Table 137. Exelixis Business Overview Table 138. Exelixis MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Exelixis MET TKIs Product Portfolio Table 140. Exelixis Recent Development Table 141. Everest Pharmaceuticals Company Information Table 142. Everest Pharmaceuticals Business Overview Table 143. Everest Pharmaceuticals MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Everest Pharmaceuticals MET TKIs Product Portfolio Table 145. Everest Pharmaceuticals Recent Development Table 146. Drug International Company Information Table 147. Drug International Business Overview Table 148. Drug International MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Drug International MET TKIs Product Portfolio Table 150. Drug International Recent Development Table 151. Cipla Company Information Table 152. Cipla Business Overview Table 153. Cipla MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Cipla MET TKIs Product Portfolio Table 155. Cipla Recent Development Table 156. Beacom Company Information Table 157. Beacom Business Overview Table 158. Beacom MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Beacom MET TKIs Product Portfolio Table 160. Beacom Recent Development Table 161. BDR Pharma Company Information Table 162. BDR Pharma Business Overview Table 163. BDR Pharma MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. BDR Pharma MET TKIs Product Portfolio Table 165. BDR Pharma Recent Development Table 166. North America MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. North America MET TKIs Sales by Country (2021-2026) & (K Units) Table 168. North America MET TKIs Sales Market Share by Country (2021-2026) Table 169. North America MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 170. North America MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 171. North America MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 173. North America MET TKIs Market Share by Country (2021-2026) Table 174. North America MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America MET TKIs Market Share Forecast by Country (2027-2032) Table 176. Europe MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Europe MET TKIs Sales by Country (2021-2026) & (K Units) Table 178. Europe MET TKIs Sales Market Share by Country (2021-2026) Table 179. Europe MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 180. Europe MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 181. Europe MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe MET TKIs Market Share by Country (2021-2026) Table 184. Europe MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe MET TKIs Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific MET TKIs Sales by Country (2021-2026) & (K Units) Table 188. Asia-Pacific MET TKIs Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 190. Asia-Pacific MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific MET TKIs Market Share by Country (2021-2026) Table 194. Asia-Pacific MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific MET TKIs Market Share Forecast by Country (2027-2032) Table 196. Latin America MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Latin America MET TKIs Sales by Country (2021-2026) & (K Units) Table 198. Latin America MET TKIs Sales Market Share by Country (2021-2026) Table 199. Latin America MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 200. Latin America MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America MET TKIs Market Share by Country (2021-2026) Table 204. Latin America MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America MET TKIs Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa MET TKIs Sales by Country (2021-2026) & (K Units) Table 208. Middle East and Africa MET TKIs Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 210. Middle East and Africa MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa MET TKIs Market Share by Country (2021-2026) Table 214. Middle East and Africa MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa MET TKIs Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. MET TKIs Distributors List Table 219. MET TKIs Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. MET TKIs Image Figure 2. Global MET TKIs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global MET TKIs Market Size (2021-2032) & (US$ Million) Figure 4. Global MET TKIs Sales (2021-2032) & (K Units) Figure 5. Multi-target Inhibitors Image Figure 6. Global Multi-target Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 7. Single-target Inhibitors Image Figure 8. Global Single-target Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global MET TKIs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global MET TKIs Market Share by Type 2025 VS 2032 Figure 11. North America MET TKIs Sales Market Share in Volume by Type in 2025 Figure 12. North America MET TKIs Sales Market Share in Value by Type in 2025 Figure 13. Europe MET TKIs Sales Market Share in Volume by Type in 2025 Figure 14. Europe MET TKIs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific MET TKIs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific MET TKIs Sales Market Share in Value by Type in 2025 Figure 17. Latin America MET TKIs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America MET TKIs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa MET TKIs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa MET TKIs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 MET TKIs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Non-small Cell Lung Cancer Image Figure 24. Global Non-small Cell Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 25. Medullary Thyroid Cancer Image Figure 26. Global Medullary Thyroid Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global MET TKIs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global MET TKIs Market Share by Application 2025 VS 2032 Figure 31. North America MET TKIs Sales Market Share in Volume by Application in 2025 Figure 32. North America MET TKIs Sales Market Share in Value by Application in 2025 Figure 33. Europe MET TKIs Sales Market Share in Volume by Application in 2025 Figure 34. Europe MET TKIs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific MET TKIs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific MET TKIs Sales Market Share in Value by Application in 2025 Figure 37. Latin America MET TKIs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America MET TKIs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa MET TKIs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa MET TKIs Sales Market Share in Value by Application in 2025 Figure 41. North America MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. MET TKIs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. MET TKIs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Multi-target Inhibitors
  • Single-target Inhibitors
Applications
  • Non-small Cell Lung Cancer
  • Medullary Thyroid Cancer
  • Other
Companies covered
  • Wanbang Biopharmaceuticals
  • CSPC Pharmaceutical
  • Asymchem
  • Shanghai Hutchison Pharmaceuticals
  • WuXi STA
  • Haihe Biopharma
  • Avistone Pharmaceuticals Biotechnology
  • Zydus
  • Teva
  • Pfizer
  • Novartis
  • Merck
  • Genvio Pharma
  • Exelixis
  • Everest Pharmaceuticals
  • Drug International
  • Cipla
  • Beacom
  • BDR Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global MET TKIs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global MET TKIs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 MET TKIs Market by Type
  6. 1.3.1 Multi-target Inhibitors
  7. 1.3.2 Single-target Inhibitors
  8. 1.4 Global MET TKIs Market Size by Type
  9. 1.4.1 Global MET TKIs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global MET TKIs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global MET TKIs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America MET TKIs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe MET TKIs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific MET TKIs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America MET TKIs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa MET TKIs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 MET TKIs Industry Trends
  2. 2.2 MET TKIs Industry Drivers
  3. 2.3 MET TKIs Industry Opportunities and Challenges
  4. 2.4 MET TKIs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by MET TKIs Revenue (2021-2026)
  2. 3.2 Global Top Players by MET TKIs Sales (2021-2026)
  3. 3.3 Global Top Players by MET TKIs Price (2021-2026)
  4. 3.4 Global MET TKIs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global MET TKIs Major Company Production Sites & Headquarters
  6. 3.6 Global MET TKIs Company, Product Type & Application
  7. 3.7 Global MET TKIs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global MET TKIs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 MET TKIs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 MET TKIs Tier 1, Tier 2, and Tier 3
4 MET TKIs Regional Status and Outlook
  1. 4.1 Global MET TKIs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global MET TKIs Historic Market Size by Region
  3. 4.2.1 Global MET TKIs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global MET TKIs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global MET TKIs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global MET TKIs Forecasted Market Size by Region
  7. 4.3.1 Global MET TKIs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global MET TKIs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global MET TKIs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 MET TKIs by Application
  1. 5.1 MET TKIs Market by Application
  2. 5.1.1 Non-small Cell Lung Cancer
  3. 5.1.2 Medullary Thyroid Cancer
  4. 5.1.3 Other
  5. 5.2 Global MET TKIs Market Size by Application
  6. 5.2.1 Global MET TKIs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global MET TKIs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global MET TKIs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America MET TKIs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe MET TKIs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific MET TKIs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America MET TKIs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa MET TKIs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wanbang Biopharmaceuticals
  2. 6.1.1 Wanbang Biopharmaceuticals Company Information
  3. 6.1.2 Wanbang Biopharmaceuticals Business Overview
  4. 6.1.3 Wanbang Biopharmaceuticals MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wanbang Biopharmaceuticals MET TKIs Product Portfolio
  6. 6.1.5 Wanbang Biopharmaceuticals Recent Developments
  7. 6.2 CSPC Pharmaceutical
  8. 6.2.1 CSPC Pharmaceutical Company Information
  9. 6.2.2 CSPC Pharmaceutical Business Overview
  10. 6.2.3 CSPC Pharmaceutical MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSPC Pharmaceutical MET TKIs Product Portfolio
  12. 6.2.5 CSPC Pharmaceutical Recent Developments
  13. 6.3 Asymchem
  14. 6.3.1 Asymchem Company Information
  15. 6.3.2 Asymchem Business Overview
  16. 6.3.3 Asymchem MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Asymchem MET TKIs Product Portfolio
  18. 6.3.5 Asymchem Recent Developments
  19. 6.4 Shanghai Hutchison Pharmaceuticals
  20. 6.4.1 Shanghai Hutchison Pharmaceuticals Company Information
  21. 6.4.2 Shanghai Hutchison Pharmaceuticals Business Overview
  22. 6.4.3 Shanghai Hutchison Pharmaceuticals MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolio
  24. 6.4.5 Shanghai Hutchison Pharmaceuticals Recent Developments
  25. 6.5 WuXi STA
  26. 6.5.1 WuXi STA Company Information
  27. 6.5.2 WuXi STA Business Overview
  28. 6.5.3 WuXi STA MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 WuXi STA MET TKIs Product Portfolio
  30. 6.5.5 WuXi STA Recent Developments
  31. 6.6 Haihe Biopharma
  32. 6.6.1 Haihe Biopharma Company Information
  33. 6.6.2 Haihe Biopharma Business Overview
  34. 6.6.3 Haihe Biopharma MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Haihe Biopharma MET TKIs Product Portfolio
  36. 6.6.5 Haihe Biopharma Recent Developments
  37. 6.7 Avistone Pharmaceuticals Biotechnology
  38. 6.7.1 Avistone Pharmaceuticals Biotechnology Company Information
  39. 6.7.2 Avistone Pharmaceuticals Biotechnology Business Overview
  40. 6.7.3 Avistone Pharmaceuticals Biotechnology MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolio
  42. 6.7.5 Avistone Pharmaceuticals Biotechnology Recent Developments
  43. 6.8 Zydus
  44. 6.8.1 Zydus Company Information
  45. 6.8.2 Zydus Business Overview
  46. 6.8.3 Zydus MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus MET TKIs Product Portfolio
  48. 6.8.5 Zydus Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva MET TKIs Product Portfolio
  54. 6.9.5 Teva Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer MET TKIs Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 Novartis
  62. 6.11.1 Novartis Company Information
  63. 6.11.2 Novartis Business Overview
  64. 6.11.3 Novartis MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Novartis MET TKIs Product Portfolio
  66. 6.11.5 Novartis Recent Developments
  67. 6.12 Merck
  68. 6.12.1 Merck Company Information
  69. 6.12.2 Merck Business Overview
  70. 6.12.3 Merck MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck MET TKIs Product Portfolio
  72. 6.12.5 Merck Recent Developments
  73. 6.13 Genvio Pharma
  74. 6.13.1 Genvio Pharma Company Information
  75. 6.13.2 Genvio Pharma Business Overview
  76. 6.13.3 Genvio Pharma MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Genvio Pharma MET TKIs Product Portfolio
  78. 6.13.5 Genvio Pharma Recent Developments
  79. 6.14 Exelixis
  80. 6.14.1 Exelixis Company Information
  81. 6.14.2 Exelixis Business Overview
  82. 6.14.3 Exelixis MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Exelixis MET TKIs Product Portfolio
  84. 6.14.5 Exelixis Recent Developments
  85. 6.15 Everest Pharmaceuticals
  86. 6.15.1 Everest Pharmaceuticals Company Information
  87. 6.15.2 Everest Pharmaceuticals Business Overview
  88. 6.15.3 Everest Pharmaceuticals MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Everest Pharmaceuticals MET TKIs Product Portfolio
  90. 6.15.5 Everest Pharmaceuticals Recent Developments
  91. 6.16 Drug International
  92. 6.16.1 Drug International Company Information
  93. 6.16.2 Drug International Business Overview
  94. 6.16.3 Drug International MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Drug International MET TKIs Product Portfolio
  96. 6.16.5 Drug International Recent Developments
  97. 6.17 Cipla
  98. 6.17.1 Cipla Company Information
  99. 6.17.2 Cipla Business Overview
  100. 6.17.3 Cipla MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Cipla MET TKIs Product Portfolio
  102. 6.17.5 Cipla Recent Developments
  103. 6.18 Beacom
  104. 6.18.1 Beacom Company Information
  105. 6.18.2 Beacom Business Overview
  106. 6.18.3 Beacom MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Beacom MET TKIs Product Portfolio
  108. 6.18.5 Beacom Recent Developments
  109. 6.19 BDR Pharma
  110. 6.19.1 BDR Pharma Company Information
  111. 6.19.2 BDR Pharma Business Overview
  112. 6.19.3 BDR Pharma MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 BDR Pharma MET TKIs Product Portfolio
  114. 6.19.5 BDR Pharma Recent Developments
7 North America by Country
  1. 7.1 North America MET TKIs Sales by Country
  2. 7.1.1 North America MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America MET TKIs Sales by Country (2021-2026)
  4. 7.1.3 North America MET TKIs Sales Forecast by Country (2027-2032)
  5. 7.2 North America MET TKIs Market Size by Country
  6. 7.2.1 North America MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America MET TKIs Market Size by Country (2021-2026)
  8. 7.2.3 North America MET TKIs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe MET TKIs Sales by Country
  2. 8.1.1 Europe MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe MET TKIs Sales by Country (2021-2026)
  4. 8.1.3 Europe MET TKIs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe MET TKIs Market Size by Country
  6. 8.2.1 Europe MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe MET TKIs Market Size by Country (2021-2026)
  8. 8.2.3 Europe MET TKIs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific MET TKIs Sales by Country
  2. 9.1.1 Asia-Pacific MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific MET TKIs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific MET TKIs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific MET TKIs Market Size by Country
  6. 9.2.1 Asia-Pacific MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific MET TKIs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific MET TKIs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America MET TKIs Sales by Country
  2. 10.1.1 South America MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America MET TKIs Sales by Country (2021-2026)
  4. 10.1.3 South America MET TKIs Sales Forecast by Country (2027-2032)
  5. 10.2 South America MET TKIs Market Size by Country
  6. 10.2.1 South America MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America MET TKIs Market Size by Country (2021-2026)
  8. 10.2.3 South America MET TKIs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa MET TKIs Sales by Country
  2. 11.1.1 Middle East and Africa MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa MET TKIs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa MET TKIs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa MET TKIs Market Size by Country
  6. 11.2.1 Middle East and Africa MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa MET TKIs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa MET TKIs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 MET TKIs Value Chain Analysis
  2. 12.1.1 MET TKIs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 MET TKIs Production Mode & Process
  7. 12.2 MET TKIs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 MET TKIs Distributors
  10. 12.2.3 MET TKIs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst